CIK 0000073290
- Non-accelerated filer
- Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 952645573
- Phone
- +1 949-379-2875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- 4 Gift Chief Financial Officer gave 16,000 shares (gift)
- 4 Other acquisition Chief Executive Officer acquired 3,600 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Executive Officer acquired 1,200 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 33,390 shares (other)
- 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
- 4 Other acquisition Director acquired 6,700 shares (other)
- 4 Other acquisition Director acquired 9,400 shares (other)
- 4 Other acquisition Director acquired 8,000 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 25,000 shares (other)
- 4 Open-market buy Chief Executive Officer bought 500 shares at $3.83 ($1,915)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at $3.96 ($3,960)
- 4 Open-market buy Chief Executive Officer bought 2,539 shares at an average $3.99 ($10,134)
Page 5 of 12 · 236 filings